For a better user experience please update your browser or use Chrome or Firefox browser.
Utilities
Publication detail
HomeReplacement, reduction and refinement of animal testing in the quality control of human vaccines
Brief description of ongoing projects
Publication metadata
Vaccines are recognised as a highly cost effective tool for preventing infectious diseases. They are derived from biological sources and due to the complexity of composition and heterogeneity of products, vaccine lots undergo legally required quality control before they are released. Traditionally, laboratory animals have played an important role in quality control of vaccines and still, many laboratory animals are used in Europe for this purpose. Over the last decades, Replacement, Reduction and Refinement (3Rs) methods to classical animal tests have been developed by control authorities, academia and vaccine manufacturers. The purpose of this report is to inform the EURL ECVAM stakeholders on ongoing activities in development and validation of 3Rs methods for the quality control of vaccines for human use. The focus of the report is on methods for lot release testing (e.g. safety, pyrogenicity, potency) and projects related to the implementation of the consistency approach to established vaccines such as diphtheria, tetanus, pertussis and rabies vaccines.
- Published:
- Personal author(s): Halder, Marlies
- Themes: Public health , Medical and biological research
- Subject: animal experimentation , health policy , medical research , product quality , research report , testing , toxicology , vaccine
|
PDF
|
|||
| ISSN 1831-9424 | ISBN 978-92-79-54174-2 | DOI 10.2788/582790 | Catalogue number LB-NA-27646-EN-N |
- Released on EU publications website:
Document viewer
Note:
The publication cannot be displayed in the document viewer. Open web version
You may access it from: Download and languages